Skip to content
GLP-1 Scorecard
Menu
Site position #517

Mojoon

Published by GLP-1 ScorecardUpdated

Premium-priced telehealth provider offering compounded semaglutide.

Visit MojoonWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$450/mo (starting dose, compounded)
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh Mojoon against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value30/100
Dose & formulation52/100
Clinical oversight74/100
Labs & monitoring53/100
Fulfillment65/100
Contract terms55/100

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

What to consider

  • Premium pricing relative to market

Bottom line — Grade C

Best for: Shoppers who want comprehensive concierge care.

Site position #517 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Mojoon — the realistic shortlist.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Mojoon's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Mojoon's site. Not medical advice; see our disclosure.

← Back to the scorecard